← Home / STAAR SURGICAL CO (STAA)
Stock Analysis

STAAR SURGICAL CO (STAA)

STAA
STAA · Healthcare • Medical Instruments & Supplies
23.54 +1.86%
Track STAA in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when STAA price is:
52W Range Position
43%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-09-03 19:41 UTC
WOI Investment Thesis
Vulnerable
Current market structure would strengthen above 26.25. Holding above 21.20 preserves the current price structure.
⚖️
✓
Fundamentals
Strong / Positive / Mixed / Strong
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
21.20
↗
Break Above
Primary setup confirms above this trigger.
25.96
🎯
Next Objective
No defined objective is currently available for the primary downtrend breakout.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
12
●
Financial Results
HIGH
STAA reports financial results
Item 7.01 Regulation FD Disclosure.
8-K Filing • SEC EDGAR
AUG
6
●
Management / Board
MEDIUM
STAA board and management update
On August 4, 2026, STAAR Surgical Company (the “Company” or “STAAR”) announced that the Company’s Board of Directors (the “Board”) appointed Warren Foust as President and Chief Executive Officer (“CEO”) and new member of the Board, effective August 4, 2026 (the “Effective Date”).
8-K Filing • SEC EDGAR
JUN
22
●
Management / Board
MEDIUM
STAA board and management update
On June 18, 2026, STAAR Surgical Company (the “Company”) held its 2026 Annual Meeting of Shareholders (the “2026 Annual Meeting”).
8-K Filing • SEC EDGAR
What's Driving STAA?
▲ Technical confirmation is pending
Momentum is Neutral. Watch Above 25.96 for setup confirmation. Structure risk is Below 21.20.
◆ Business quality is mixed
Revenue growth is strong. Profitability is positive. Cash generation is mixed. Balance-sheet quality is strong.
⚠️ Key risk remains
Below 21.20
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
A technical structure is developing but has not yet reached confirmed active status.
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
25.96
RSI(14)
47.1
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 21.20 and resistance around 26.25. The chart still needs to reclaim resistance to improve meaningfully, while any loss of support would keep weakness in control.
Price Chart
STAA — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-09-02
Premium
Premium valuation
The stock trades at elevated earnings or cash-flow multiples; quality must justify the price.
Market Cap
$1.2B
Company size
EV
$1.0B
Debt-adjusted value
P/E
294.0
Very high
P/S
3.5
Low sales multiple
P/B
3.2
Balanced
EV/Sales
3.0
Low sales multiple
EV/EBIT
28.0
Reasonable
P/FCF
76.8
Very high
FCF Yield
1.30%
Cash return
Not financial advice
Business Lens
Improving financial execution
Revenue and profitability remain supportive, while cash flow and balance sheet quality require monitoring.
↗
Revenue Growth
Strong
●
Profitability
Positive
≈
Cash Flow
Mixed
⚖
Balance Sheet
Strong
💵 Revenue
93.53M
↗ Strong
📈 Net Income
8.06M
↗ Positive
🧮 EPS (Basic)
0.16
↗ Positive
STAAR SURGICAL CO
Healthcare • Medical Instruments & Supplies
You Might Also Like